Metastatic in Medical Technology
Navigation Links
Metastatic in Medical Technology
... treatment of patients with KRAS wild-type metastatic colorectal cancer (mCRC).
"We believe ... document an important advance for patients with metastatic colorectal cancer," said Roger M. Perlmutter, ... agent for the treatment of EGFR-expressing, metastatic colorectal carcinoma is based on progression-free ...
... long-term survival rates in patients with metastatic melanoma whose disease had been minimized by ... Anti-Tumor Vaccines in Patients with metastatic Melanoma," was published in the June 2009 issue ... for melanoma patients with recurrent or distant metastatic disease at the time of diagnosis because there ...
... Progesterone Receptor (PR), and HER2-negative metastatic breast cancer. Joyce O'Shaughnessy, ... which is a very promising new treatment for metastatic triple negative breast cancer," says Dr. ... include adults with histologically documented metastatic breast cancer with measurable disease that is ...
... carboplatin (GC) chemotherapy, in patients with metastatic triple-negative breast cancer (TNBC). BSI-201 is ... damage. In this study, 116 women with metastatic TNBC, defined as tumors lacking expression of ... expect to begin a Phase 3 trial with BSI-201 in metastatic TNBC this summer. About ASCO ASCO ...
... XERECEPT(R) in Patients with Primary and metastatic Brain Tumors Administration of XERECEPT(R) ... cerebral edema associated with both primary and metastatic brain tumors. The Company also announced the ... use over the longer-term and the impact seen in metastatic patients, a large group with limited treatment ...
... + Placebo in Patients with 2nd or 3rd Line metastatic Colon Cancer NEW YORK, June 1 ... alone in patients with second- or third-line metastatic colon cancer," was presented yesterday in a ... the United States, patients with 2nd or 3rd line metastatic colon cancer were randomized to receive ...
... to the liver, lung and bone[i]. Historically, metastatic melanoma patients live less than two months ... if caught early but patients who develop metastatic disease are rarely cured with available ... been observed - Regression of metastatic lesions in every site to which melanoma ...
... locally advanced (Stage IIIA or Stage IIIB) or metastatic (Stage IV or cancer that has spread) non-small ... II or Stage III when surgery is not an option) or metastatic (Stage IV) adenocarcinoma of the pancreas. GEMZAR ... FDA for the first-line treatment of patients with metastatic breast cancer after they have received another ...
... + Placebo in Patients with 2nd or 3rd Line metastatic Colon Cancer NEW YORK, May 31 ... alone in patients with second- or third-line metastatic colon cancer," is being presented today in a ... the United States, patients with 2nd or 3rd line metastatic colon cancer were randomized to receive ...
... #5034, entitled, "Phase II study of perifosine in metastatic renal cell carcinoma (RCC) progressing after ... clinical benefit to patients with 2nd or 3rd line metastatic renal cell cancer. We are grateful to Dr. ... therapies for the treatment of advanced metastatic RCC (VEGF inhibitors, sunitinib and sorafenib, ...
... medical need for more therapies for patients with metastatic breast cancer. These data warrant ongoing and ... phase 1 portion (part 1), and only patients with metastatic ErbB-2 positive breast cancer were enrolled in ... investigated in patients with ErbB-2 positive metastatic breast cancer. A total of 102 patients ...
... Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). The new data ... activity in the treatment of first-line metastatic CRC, as assessed by progression-free survival ... regimen is the current standard of care for metastatic colorectal cancer, but is associated with severe ...
... need of new treatments." Sandostatin LAR in metastatic neuroendocrine midgut tumors Data from the ... a significant antitumor effect in patients with metastatic neuroendocrine tumors (NET) of the midgut(1). ... efficacy of O ctreotide LAR in patients with metastatic neuroendocrine MID gut tumors), is a Phase IIIb ...
... abstract submission. Three patients had distant metastatic disease. Two of these were in the low dose group. ... the immune system to destroy un-injected metastatic deposits. Both modes of action have been clearly ... in the clinic, where multiple patients with metastatic disease progressing at enrollment have been ...
... plus docetaxel/prednisone in patients with metastatic castration-resistant (hormone-refractory) ... picoplatin plus 5-FU/leucovorin in patients with metastatic colorectal cancer (CRC). Both presentations ... in small cell lung cancer and Phase 2 trials in metastatic colorectal and castration-resistant (hormone ...
... with docetaxel and prednisone in patients with metastatic castration-resistant (hormone-refractory) ... and prednisone, the standard treatment for metastatic CRPC, supporting the use of this combination in ... and leucovorin (FOLPI) in patients with metastatic colorectal cancer (CRC) at the ASCO 2009 ...
... its Phase 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 ... for Provectus' Phase 2 study of PV-10 for metastatic melanoma, Professor John F Thompson, MD, ... 120,000 patients in the U.S. alone have metastatic melanoma, and the World Health Organization ...
... of this trial at NCI. Capstran had stage-four metastatic melanoma, a diagnosis that few survive, but with ... the NCI are exciting for patients with stage-four metastatic melanoma. Published reports for the trial show a ... all patients must be diagnosed with stage-four metastatic melanoma. During the trial blood is drawn from ...
... issues, finds that a first-line therapy for metastatic renal cell carcinoma that can increase overall ... surveyed oncologists' prescribing decisions in metastatic renal cell carcinoma. Clinical data and the ... proprietary clinical gold standard in 2008 for metastatic renal cell carcinoma. Based on available ...
... administration of REOLYSIN(R) in patients with metastatic colorectal cancer prior to surgical resection of ... operations to remove colorectal cancer deposits metastatic to the liver. Patients will comprise two groups ... to the U.K. translational study for patients with metastatic colorectal cancer with liver metastases, and the ...
... as a new, safe and effective treatment for metastatic prostate cancer. The program has demonstrated ... generated so far for Alpharadin in treating metastatic prostate cancer are highly encouraging and offer ... nature of Alpharadin. ALP is a severity marker of metastatic bone disease and of prognostic importance. Again, ...
... advanced gastric cancer (inoperable, recurrent or metastatic gastric cancer) whose disease progressed despite ... phase II study of RAD001 for previously treated metastatic gastric cancer. Presented at the American Society ... 23, 2008. (3) Ohtsu, A. Chemotherapy for metastatic gastric cancer: past, present, and future. J ...
... demonstrated antitumor benefit in patients with metastatic neuroendocrine tumors (NETs) of the midgut, ... efficacy of O ctreotide LAR in patients with metastatic neuroendocrine MID gut tumors). ... also helps control tumor growth in patients with metastatic neuroendocrine tumors of the midgut," said PROMID ...
... from a Phase 3 study show that patients with metastatic breast cancer who were treated previously with an ... "Anthracyclines are active drugs for metastatic breast cancer, but concerns about cardiac ... be an effective treatment for patients with metastatic breast cancer who have relapsed after prior ...
... (trastuzumab)* in women with HER2-positive metastatic breast cancer. These results support the ... growth in 77% of patients with HER2-positive metastatic breast cancer with documented resistance to ... Herceptin-resistant patients with HER2-positive metastatic breast cancer. In the study, RAD001 in ...
... and trastuzumab in HER-2-overexpressing metastatic breast cancer with prior resistance to ... trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to ... arthritis and bone fracture. In the metastatic cancer setting, commonly reported side effects ...
... ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer. The current ... the Phase 2 randomized study in 82 patients with metastatic or locally recurring prostate cancer refractory ... in combination with docetaxel for progressive metastatic prostate cancer. Recently, the FDA confirmed the ...
... in an ongoing Phase II trial in patients with metastatic breast cancer who have received previous ... data from more frequent dosing in patients with metastatic melanoma and from the Phase II study in patients ... treatment of melanoma and for the treatment of metastatic breast cancer, and in a Phase I trial to ...
... a specific, targeted immune response that attacks metastatic cells in the prostate. Conventional chemotherapy ... continuously improved. However, the treatment for metastatic prostate cancer has not been improved in ... agent approved for the treatment of metastatic prostate cancer that extends survival by ~ 2 ...
... a specific, targeted immune response that attacks metastatic cells in the prostate. Conventional chemotherapy ... continuously improved. However, the treatment for metastatic prostate cancer has not been improved in ... agent approved for the treatment of metastatic prostate cancer that extends survival by - 2 ...
... Netherlands, and the United Kingdom, found that metastatic colorectal cancer patients with fewer than three ... "Obtaining measurements of CTCs for patients with metastatic colorectal cancer beginning a new therapy ... Survival, and Overall Survival in Patients with metastatic Colorectal Cancer," which summarizes data from a ...
... long-term survival rates in patients with metastatic melanoma whose disease had been minimized by ... Anti-Tumor Vaccines in Patients with metastatic Melanoma," was published in the June 2009 issue ... for melanoma patients with recurrent or distant metastatic disease at the time of diagnosis because there ...
... Progesterone Receptor (PR), and HER2-negative metastatic breast cancer. Joyce O'Shaughnessy, ... which is a very promising new treatment for metastatic triple negative breast cancer," says Dr. ... include adults with histologically documented metastatic breast cancer with measurable disease that is ...
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
... treatment of melanoma and for the treatment of metastatic breast cancer, and in a Phase I trial to evaluate ... in therapy, the median survival of patients with metastatic breast cancer is 2 to 3 years, while patients ... approaches for patients with locally advanced and metastatic breast cancer who have failed other therapies. ...... carboplatin (GC) chemotherapy, in patients with metastatic triple-negative breast cancer (TNBC). BSI-201 is ... damage. In this study, 116 women with metastatic TNBC, defined as tumors lacking expression of ... expect to begin a Phase 3 trial with BSI-201 in metastatic TNBC this summer. About ASCO ASCO ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... median number of prior chemotherapy regimens for metastatic disease was 4 (range 2-11). Triple negative ... expand the activity of CR011 into patients with metastatic breast cancer and open this area up as an ... in addition to the opportunity in patients with metastatic melanoma," commented Dr. Timothy Shannon, ...... XERECEPT(R) in Patients with Primary and metastatic Brain Tumors Administration of XERECEPT(R) ... cerebral edema associated with both primary and metastatic brain tumors. The Company also announced the ... use over the longer-term and the impact seen in metastatic patients, a large group with limited treatment ...
... + Placebo in Patients with 2nd or 3rd Line metastatic Colon Cancer NEW YORK, June 1 ... alone in patients with second- or third-line metastatic colon cancer," was presented yesterday in a ... the United States, patients with 2nd or 3rd line metastatic colon cancer were randomized to receive ...
... to the liver, lung and bone[i]. Historically, metastatic melanoma patients live less than two months ... if caught early but patients who develop metastatic disease are rarely cured with available ... been observed - Regression of metastatic lesions in every site to which melanoma ...
... locally advanced (Stage IIIA or Stage IIIB) or metastatic (Stage IV or cancer that has spread) non-small ... II or Stage III when surgery is not an option) or metastatic (Stage IV) adenocarcinoma of the pancreas. GEMZAR ... FDA for the first-line treatment of patients with metastatic breast cancer after they have received another ...
... + Placebo in Patients with 2nd or 3rd Line metastatic Colon Cancer NEW YORK, May 31 ... alone in patients with second- or third-line metastatic colon cancer," is being presented today in a ... the United States, patients with 2nd or 3rd line metastatic colon cancer were randomized to receive ...
... #5034, entitled, "Phase II study of perifosine in metastatic renal cell carcinoma (RCC) progressing after ... clinical benefit to patients with 2nd or 3rd line metastatic renal cell cancer. We are grateful to Dr. ... therapies for the treatment of advanced metastatic RCC (VEGF inhibitors, sunitinib and sorafenib, ...
... medical need for more therapies for patients with metastatic breast cancer. These data warrant ongoing and ... phase 1 portion (part 1), and only patients with metastatic ErbB-2 positive breast cancer were enrolled in ... investigated in patients with ErbB-2 positive metastatic breast cancer. A total of 102 patients ...
... Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). The new data ... activity in the treatment of first-line metastatic CRC, as assessed by progression-free survival ... regimen is the current standard of care for metastatic colorectal cancer, but is associated with severe ...
CuraGen to Present CR011-vcMMAE Data at ASCO
... conjugate, in patients with locally advanced or metastatic breast cancer. Monday, June 1, 2009, poster ... treatment of melanoma and for the treatment of metastatic breast cancer, and in a Phase I trial to evaluate ... in therapy, the median survival of patients with metastatic breast cancer is 2 to 3 years, while patients ...... need of new treatments." Sandostatin LAR in metastatic neuroendocrine midgut tumors Data from the ... a significant antitumor effect in patients with metastatic neuroendocrine tumors (NET) of the midgut(1). ... efficacy of O ctreotide LAR in patients with metastatic neuroendocrine MID gut tumors), is a Phase IIIb ...
... abstract submission. Three patients had distant metastatic disease. Two of these were in the low dose group. ... the immune system to destroy un-injected metastatic deposits. Both modes of action have been clearly ... in the clinic, where multiple patients with metastatic disease progressing at enrollment have been ...
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
... study of picoplatin in patients with metastatic colorectal cancer (CRC) was presented at the ... to oxaliplatin for the first-line treatment of metastatic CRC. Patient enrollment was completed in May ... trials of picoplatin as first-line treatment for metastatic colorectal and castration-resistant prostate ...... plus docetaxel/prednisone in patients with metastatic castration-resistant (hormone-refractory) ... picoplatin plus 5-FU/leucovorin in patients with metastatic colorectal cancer (CRC). Both presentations ... in small cell lung cancer and Phase 2 trials in metastatic colorectal and castration-resistant (hormone ...
Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
... CANCER CENTER JOINS PHASE III TRIAL FOR metastatic MELANOMA NEW YORK, April 9 ... Phase III clinical trial for the treatment of metastatic melanoma in the liver. Ohio State is the ... look forward to treating patients in this trial. metastatic melanoma, once it reaches the liver, has few ...... with docetaxel and prednisone in patients with metastatic castration-resistant (hormone-refractory) ... and prednisone, the standard treatment for metastatic CRPC, supporting the use of this combination in ... and leucovorin (FOLPI) in patients with metastatic colorectal cancer (CRC) at the ASCO 2009 ...
... its Phase 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 ... for Provectus' Phase 2 study of PV-10 for metastatic melanoma, Professor John F Thompson, MD, ... 120,000 patients in the U.S. alone have metastatic melanoma, and the World Health Organization ...
... of this trial at NCI. Capstran had stage-four metastatic melanoma, a diagnosis that few survive, but with ... the NCI are exciting for patients with stage-four metastatic melanoma. Published reports for the trial show a ... all patients must be diagnosed with stage-four metastatic melanoma. During the trial blood is drawn from ...
Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps
... procedure to treat the painful effects of metastatic bone disease by injecting bone cement to support ... of life can be severely affected when they have metastatic bone disease. Normal daily activities can become ... of their primary cancers," added Anselmetti. metastatic bone disease is a painful condition that can ...... issues, finds that a first-line therapy for metastatic renal cell carcinoma that can increase overall ... surveyed oncologists' prescribing decisions in metastatic renal cell carcinoma. Clinical data and the ... proprietary clinical gold standard in 2008 for metastatic renal cell carcinoma. Based on available ...
... administration of REOLYSIN(R) in patients with metastatic colorectal cancer prior to surgical resection of ... operations to remove colorectal cancer deposits metastatic to the liver. Patients will comprise two groups ... to the U.K. translational study for patients with metastatic colorectal cancer with liver metastases, and the ...
... as a new, safe and effective treatment for metastatic prostate cancer. The program has demonstrated ... generated so far for Alpharadin in treating metastatic prostate cancer are highly encouraging and offer ... nature of Alpharadin. ALP is a severity marker of metastatic bone disease and of prognostic importance. Again, ...
... advanced gastric cancer (inoperable, recurrent or metastatic gastric cancer) whose disease progressed despite ... phase II study of RAD001 for previously treated metastatic gastric cancer. Presented at the American Society ... 23, 2008. (3) Ohtsu, A. Chemotherapy for metastatic gastric cancer: past, present, and future. J ...
... demonstrated antitumor benefit in patients with metastatic neuroendocrine tumors (NETs) of the midgut, ... efficacy of O ctreotide LAR in patients with metastatic neuroendocrine MID gut tumors). ... also helps control tumor growth in patients with metastatic neuroendocrine tumors of the midgut," said PROMID ...
... from a Phase 3 study show that patients with metastatic breast cancer who were treated previously with an ... "Anthracyclines are active drugs for metastatic breast cancer, but concerns about cardiac ... be an effective treatment for patients with metastatic breast cancer who have relapsed after prior ...
... (trastuzumab)* in women with HER2-positive metastatic breast cancer. These results support the ... growth in 77% of patients with HER2-positive metastatic breast cancer with documented resistance to ... Herceptin-resistant patients with HER2-positive metastatic breast cancer. In the study, RAD001 in ...
... and trastuzumab in HER-2-overexpressing metastatic breast cancer with prior resistance to ... trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to ... arthritis and bone fracture. In the metastatic cancer setting, commonly reported side effects ...
... ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer. The current ... the Phase 2 randomized study in 82 patients with metastatic or locally recurring prostate cancer refractory ... in combination with docetaxel for progressive metastatic prostate cancer. Recently, the FDA confirmed the ...
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
... of Allovectin-7(R) in patients with advanced metastatic melanoma, we are also looking ahead to ... an immune response against both local and distant metastatic tumors. Vical conducted a large Phase 2 ... a single agent for patients with Stage III or IV metastatic melanoma. Based on advice from clinical experts ...... in an ongoing Phase II trial in patients with metastatic breast cancer who have received previous ... data from more frequent dosing in patients with metastatic melanoma and from the Phase II study in patients ... treatment of melanoma and for the treatment of metastatic breast cancer, and in a Phase I trial to ...
... a specific, targeted immune response that attacks metastatic cells in the prostate. Conventional chemotherapy ... continuously improved. However, the treatment for metastatic prostate cancer has not been improved in ... agent approved for the treatment of metastatic prostate cancer that extends survival by ~ 2 ...
... a specific, targeted immune response that attacks metastatic cells in the prostate. Conventional chemotherapy ... continuously improved. However, the treatment for metastatic prostate cancer has not been improved in ... agent approved for the treatment of metastatic prostate cancer that extends survival by - 2 ...
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
... is an important quality of life benefit in metastatic cancer patients. The trial also confirmed ... dose levels of Alpharadin in patients with bony metastatic HRPC. The drug was given by i.v. injection mainly ... dose groups. ALP is a severity marker of bony metastatic disease and of prognostic importance. The study ...U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
... of REOLYSIN(R) in patients with metastatic malignant melanoma, as well as the safety profile ... is expected to enroll up to 47 patients with metastatic melanoma. Approximately 60,000 people are ... administration clinical trial for patients with metastatic melanoma, and the Company's belief as to the ...... Netherlands, and the United Kingdom, found that metastatic colorectal cancer patients with fewer than three ... "Obtaining measurements of CTCs for patients with metastatic colorectal cancer beginning a new therapy ... Survival, and Overall Survival in Patients with metastatic Colorectal Cancer," which summarizes data from a ...
Other Contentsspectrumspectrumspectrumspectrumspectrumspectrumspectrumspectrumspectrumopticalopticalopticalopticalopticalopticalopticalopticalopticalvisionvisionvisionvisionvisionvisionvisionvisionvitaminvitaminvitaminvitaminvitaminvitaminvitaminvitaminwavelengthwavelengthwavelengthwavelengthwavelengthwavelengthwavelengthpairpairpairpairpairpairpairpairbasebasebasebasebasebasebasebasebase
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How nutrition affects healthy aging 2Papillomavirus silences innate immune response 2BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5CBI Hosts Life Sciences Summit on International Trade Compliance 14047 1CBI Hosts Life Sciences Summit on International Trade Compliance 14047 2Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 1Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 2Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 3Universal Medical Systems of Ohio Introduces Charlie Worlds First Portable Battery Operated Multi Slice CT Scanner for Pets 57156 4
Breaking Medicine News(10 mins):Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:Pitt study suggests craving hinders comprehension without you realizing it 2Health News:EPA: Greenhouse Gases Hazardous to Your Health 2Health News:EPA: Greenhouse Gases Hazardous to Your Health 3Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 2Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 3Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 4Health News:Hospice Foundation of America Presents Webinar on 'Bereavement Camps for Kids: Benefits and Challenges' 2
Other TagsLouis[0] Prostate Hormone Therapy May Up Heart Risks[0] Pitt study suggests craving hinders comprehension without you realizing it[0] EPA: Greenhouse Gases Hazardous to Your Health [1] Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization[0] Hospice Foundation of America Presents Webinar on 'Bereavement Camps for Kids: Benefits and Challenges'
KlinefelterKonradLifeformLineweaverLouisMacroecologyMacromoleculeMarcelloMathematicalMichaelisMicroorganismMutationalMullerNicotinamide
Other Tagselasticity 2induces 2induces 3induces 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |